Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocept Inc (NQ: BIOC )

6.460 USD +0.430 (+7.13%)
Official Closing Price Updated: 5:57 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 208,400
Open 6.190
Bid (Size) 6.350 (11)
Ask (Size) 6.470 (1)
Prev. Close 6.030
Today's Range 6.160 - 6.550
52wk Range 2.100 - 13.00
Shares Outstanding 68,213,349
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biocept to Present at H.C. Wainwright Virtual BioConnect Conference
CEO Michael Nall to participate in diagnostics and devices panel discussion hosted by former FDA Commissioner Dr. Scott Gottlieb 
From PR Newswire
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve... 
From PR Newswire

Performance

YTD
+36.29%
+36.29%
1 Month
+6.25%
+6.25%
3 Month
+39.83%
+39.83%
6 Month
-2.86%
-2.86%
1 Year
+43.56%
+43.56%

More News

Read More
Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients
From Business Wire News Releases
Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations
From PR Newswire
Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients
From Business Wire News Releases
Biocept Provides Business Update
From PR Newswire
Biocept Provides Update on COVID-19 Testing with More than 250,000 Samples Received
From Business Wire News Releases
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Biocept Issues Letter to Stockholders
From Business Wire News Releases
Biocept's Target Selector™ Liquid Biopsy Demonstrated High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center
From PR Newswire
While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare Launches MedModLabs to Expand Access Immediately
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.